Citations (17)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Yangwei Fan, Ke Ma, Chuying Wang, Jing Ning, Yuan Hu, Danfeng Dong, Xuyuan Dong, Qianqian Geng, Enxiao Li & Yinying Wu. (2016) Prognostic value of PD-L1 and PD-1 expression in pulmonary neuroendocrine tumors. OncoTargets and Therapy 9, pages 6075-6082.
Read now
Read now
Assunta Sgambato, Francesca Casaluce, Paolo Maione, Antonio Rossi, Paola Claudia Sacco, Filomena Panzone, Fortunato Ciardiello & Cesare Gridelli. (2013) Medical treatment of small cell lung cancer: state of the art and new development. Expert Opinion on Pharmacotherapy 14:15, pages 2019-2031.
Read now
Read now
Articles from other publishers (15)
Chenyue Zhang & Haiyong Wang. (2022) Accurate treatment of small cell lung cancer: Current progress, new challenges and expectations. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 1877:5, pages 188798.
Crossref
Crossref
Hui Li, Yan Liu, Xianhong Liu, Dandan Zhao, Jingjing Liu & Ying Cheng. (2020) A novel multi-target tyrosine kinase inhibitor anlotinib combined with irinotecan has in-vitro anti-tumor activity against human small-cell lung cancer. Anti-Cancer Drugs 31:10, pages 1057-1064.
Crossref
Crossref
Shanmuga Subbiah, Arin Nam, Natasha Garg, Amita Behal, Prakash Kulkarni & Ravi Salgia. (2020) Small Cell Lung Cancer from Traditional to Innovative Therapeutics: Building a Comprehensive Network to Optimize Clinical and Translational Research. Journal of Clinical Medicine 9:8, pages 2433.
Crossref
Crossref
Haiyue Wang, Zhongwu Li, Bin Dong, Wei Sun, Xin Yang, Ruping Liu, Lixin Zhou, Xiaozheng Huang, Ling Jia & Dongmei Lin. (2018) Prognostic significance of PD-L1 expression and CD8+ T cell infiltration in pulmonary neuroendocrine tumors. Diagnostic Pathology 13:1.
Crossref
Crossref
Takanobu Jotatsu, Shigehiro Yagishita, Ken Tajima, Fumiyuki Takahashi, Kaoru Mogushi, Moulid Hidayat, Aditya Wirawan, Ryo Ko, Ryota Kanemaru, Naoko Shimada, Keiko Mitani, Tsuyoshi Saito, Kazuya Takamochi, Kenji Suzuki, Shinji Kohsaka, Shinya Kojima, Hiroshi Mukae, Kazuhiro Yatera & Kazuhisa Takahashi. (2017) LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer. Biochemistry and Biophysics Reports 9, pages 86-94.
Crossref
Crossref
Shaun C. Offerman, Manikandan Kadirvel, Osama H. Abusara, Jennifer L. Bryant, Brian A. Telfer, Gavin Brown, Sally Freeman, Anne White, Kaye J. Williams & Harmesh S. Aojula. (2017) N-tert-Prenylation of the indole ring improves the cytotoxicity of a short antagonist G analogue against small cell lung cancer. MedChemComm 8:3, pages 551-558.
Crossref
Crossref
Ruixiang Tang, Yingying Lei, Bingshuang Hu, Jie Yang, Shun Fang, Qiongyao Wang, Man Li & Linlang Guo. (2016) WW domain binding protein 5 induces multidrug resistance of small cell lung cancer under the regulation of miR-335 through the Hippo pathway. British Journal of Cancer 115:2, pages 243-251.
Crossref
Crossref
Adam Sharp, Jaishree Bhosle, Fatma Abdelraouf, Sanjay Popat, Mary O'Brien & Timothy A. Yap. (2016) Development of molecularly targeted agents and immunotherapies in small cell lung cancer. European Journal of Cancer 60, pages 26-39.
Crossref
Crossref
Umberto Miglio, Rosanna Mezzapelle, Alessia Paganotti, Claudia Veggiani, Francesca Mercalli, Giuseppe Mancuso, Erica Gaudino, Ottavio Rena, Roberta Buosi & Renzo Boldorini. (2015)
Frequency of O
6
-methylguanine-DNA methyltransferase promoter methylation in cytological samples from small cell lung cancer
. Diagnostic Cytopathology 43:11, pages 947-952.
Crossref
Crossref
Anne M. Schultheis, Andreas H. Scheel, Luka Ozretić, Julie George, Roman K. Thomas, Thorsten Hagemann, Thomas Zander, Jürgen Wolf & Reinhard Buettner. (2015) PD-L1 expression in small cell neuroendocrine carcinomas. European Journal of Cancer 51:3, pages 421-426.
Crossref
Crossref
Yifeng Bai, Yanqin Sun, Juan Peng, Hongzhan Liao, Hongyi Gao, Ying Guo & Linlang Guo. (2014) Overexpression of secretagogin inhibits cell apoptosis and induces chemoresistance in small cell lung cancer under the regulation of miR-494. Oncotarget 5:17, pages 7760-7775.
Crossref
Crossref
Anne M Schultheis, Marc Bos, Katja Schmitz, Lea Wilsberg, Elke Binot, Jürgen Wolf, Reinhard Büttner & Hans-Ulrich Schildhaus. (2014) Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential therapeutic target in small-cell lung cancer. Modern Pathology 27:2, pages 214-221.
Crossref
Crossref
Niki Karachaliou, Chara Papadaki, Eleni Lagoudaki, Maria Trypaki, Maria Sfakianaki, Anastasios Koutsopoulos, Dimitris Mavroudis, Efstathios Stathopoulos, Vassilis Georgoulias & John Souglakos. (2013) Predictive Value of BRCA1, ERCC1, ATP7B, PKM2, TOPOI, TOPΟ-IIA, TOPOIIB and C-MYC Genes in Patients with Small Cell Lung Cancer (SCLC) Who Received First Line Therapy with Cisplatin and Etoposide. PLoS ONE 8:9, pages e74611.
Crossref
Crossref
Roland Hubaux, Kelsie L. Thu, Bradley P. Coe, Calum MacAulay, Stephen Lam & Wan L. Lam. (2013) EZH2 Promotes E2F-Driven SCLC Tumorigenesis through Modulation of Apoptosis and Cell-Cycle Regulation. Journal of Thoracic Oncology 8:8, pages 1102-1106.
Crossref
Crossref
Martina Sollini, Daniela Farioli, Armando Froio, Antonio Chella, Mattia Asti, Roberto Boni, Elisa Grassi, Massimo Roncali, Annibale Versari & Paola Anna Erba. (2013) Brief Report on the Use of Radiolabeled Somatostatin Analogs for the Diagnosis and Treatment of Metastatic Small-Cell Lung Cancer Patients. Journal of Thoracic Oncology 8:8, pages 1095-1101.
Crossref
Crossref